Journal
MOLECULES
Volume 27, Issue 7, Pages -Publisher
MDPI
DOI: 10.3390/molecules27072220
Keywords
triterpenoic acid; ursolic acid; oleanolic acid; betulinic acid; rhodamine B; rhodamine 101; cytotoxicity
Funding
- Muller (Dept. Oncology, Martin-Luther-University Halle-Wittenberg)
Ask authors/readers for more resources
Pentacyclic triterpenoic acids were modified and coupled with either rhodamine B or rhodamine 101, resulting in compounds with enhanced cytotoxicity, especially the ones containing rhodamine 101 residue which showed significant inhibition against ovarian cancer cells.
Pentacyclic triterpenoic acids (betulinic, oleanolic, ursolic, and platanic acid) were selected and subjected to acetylation followed by the formation of amides derived from either piperazine or homopiperazine. These amides were coupled with either rhodamine B or rhodamine 101. All of these compounds were screened for their cytotoxic activity in SRB assays. As a result, the cytotoxicity of the parent acids was low but increased slightly upon their acetylation while a significant increase in cytotoxicity was observed for piperazinyl and homopiperazinyl amides. A tremendous improvement in cytotoxicity was observed; however, for the rhodamine B and rhodamine 101 conjugates, and compound 27, an ursolic acid derived homopiperazinyl amide holding a rhodamine 101 residue showed an EC50 = 0.05 mu M for A2780 ovarian cancer cells while being less cytotoxic for non-malignant fibroblasts. To date, the rhodamine 101 derivatives presented here are the first examples of triterpene derivatives holding a rhodamine residue different from rhodamine B.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available